Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits

K Brandl, G Plitas, CN Mihu, C Ubeda, T Jia, M Fleisher… - Nature, 2008 - nature.com
K Brandl, G Plitas, CN Mihu, C Ubeda, T Jia, M Fleisher, B Schnabl, RP DeMatteo
Nature, 2008nature.com
Infection with antibiotic-resistant bacteria, such as vancomycin-resistant Enterococcus
(VRE), is a dangerous and costly complication of broad-spectrum antibiotic therapy,. How
antibiotic-mediated elimination of commensal bacteria promotes infection by antibiotic-
resistant bacteria is a fertile area for speculation with few defined mechanisms. Here we
demonstrate that antibiotic treatment of mice notably downregulates intestinal expression of
RegIIIγ (also known as Reg3g), a secreted C-type lectin that kills Gram-positive bacteria …
Abstract
Infection with antibiotic-resistant bacteria, such as vancomycin-resistant Enterococcus (VRE), is a dangerous and costly complication of broad-spectrum antibiotic therapy,. How antibiotic-mediated elimination of commensal bacteria promotes infection by antibiotic-resistant bacteria is a fertile area for speculation with few defined mechanisms. Here we demonstrate that antibiotic treatment of mice notably downregulates intestinal expression of RegIIIγ (also known as Reg3g), a secreted C-type lectin that kills Gram-positive bacteria, including VRE. Downregulation of RegIIIγ markedly decreases in vivo killing of VRE in the intestine of antibiotic-treated mice. Stimulation of intestinal Toll-like receptor 4 by oral administration of lipopolysaccharide re-induces RegIIIγ, thereby boosting innate immune resistance of antibiotic-treated mice against VRE. Compromised mucosal innate immune defence, as induced by broad-spectrum antibiotic therapy, can be corrected by selectively stimulating mucosal epithelial Toll-like receptors, providing a potential therapeutic approach to reduce colonization and infection by antibiotic-resistant microbes.
nature.com